CollPlant Biotechnologies Ltd.

CLGN ·Healthcare, Medical Devices, Israel
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 Feb 6, 2026 PROSPECTUS SUPPLEMENT
6-K Feb 5, 2026 REPORT OF FOREIGN PRIVATE ISSUER
EFFECT Jan 16, 2026
CORRESP Jan 15, 2026
UPLOAD Jan 14, 2026
F-3 Jan 9, 2026 REGISTRATION STATEMENT
6-K Dec 31, 2025 REPORT OF FOREIGN PRIVATE ISSUER
SCHEDULE 13D/A Nov 28, 2025
6-K Nov 26, 2025 REPORT OF FOREIGN PRIVATE ISSUER
6-K Nov 26, 2025 REPORT OF FOREIGN PRIVATE ISSUER
SCHEDULE 13D/A Nov 7, 2025
6-K Oct 27, 2025 REPORT OF FOREIGN PRIVATE ISSUER
SCHEDULE 13D/A Oct 20, 2025
6-K Oct 20, 2025 REPORT OF FOREIGN PRIVATE ISSUER
6-K Oct 16, 2025 REPORT OF FOREIGN PRIVATE ISSUER
144 Oct 9, 2025
SCHEDULE 13D Sep 30, 2025
6-K Sep 30, 2025 REPORT OF FOREIGN PRIVATE ISSUER
6-K Sep 15, 2025 REPORT OF FOREIGN PRIVATE ISSUER
6-K Sep 12, 2025 REPORT OF FOREIGN PRIVATE ISSUER
EFFECT Aug 28, 2025
POS AM Aug 20, 2025 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1
6-K Aug 20, 2025 REPORT OF FOREIGN PRIVATE ISSUER
6-K Jul 14, 2025 REPORT OF FOREIGN PRIVATE ISSUER
EFFECT Jul 3, 2025
← Newer Page 3 of 14 · 343 filings Older →